SCHEDULE 13G

Company

BIOCRYST PHARMACEUTICALS INC

Filed

March 14, 2016

Accession Number

0001144204-16-087822

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →